Uppsala
From The Long Sepsis, an encyclopedia of a world that didn't happen
Uppsala is a city of 160,000 in central Sweden, lying on the River Fyris about seventy kilometres north of Stockholm. It is the seat of Uppsala University, founded in 1477, whose medical school rose to international prominence during the twentieth century as one of Europe's primary centres for the study and clinical application of serum therapy.
The Uppsala medical faculty entered the modern era of bacterial medicine through a tradition of surgical pathology dating to the 1920s. When reliable systemic antibacterial treatment failed to materialize, Uppsala's clinicians and researchers turned their attention to passive immunization. The university's hospital, the Akademiska Sjukhuset, began systematic trials of serum therapy protocols in the 1950s, shortly after the Bacillary Congress of Geneva had formalized asepsis maximalism as the international standard for infection control.
Under the direction of the physician and bacteriologist Sven Höglund, Uppsala's medical school rebuilt its teaching curriculum around serum pharmacology rather than chemical antimicrobials. This shift required new clinical skills — recognizing when serum therapy was appropriate, managing the timing of passive immunization, and monitoring patient response to animal-derived antibodies. The university's clinical records from 1955 onward document systematic infection outcomes using the newly developed Kaplan-Meier method, positioning Uppsala's hospital as an early centre for the statistical study of serum therapy efficacy.
In 1963, Uppsala University established the Institute for Immunological Therapy, a dedicated research unit focused on optimizing serum therapy protocols for conditions that had previously been untreatable. The institute's researchers collaborated directly with specialized serum farms across Scandinavia to ensure consistent antibody quality and to study the relationship between animal immunization schedules and serum potency. The institute's work on meningitis and endocarditis treatment became particularly influential, establishing reference protocols that were adopted by the Geneva Sanitary Bureau in the 1970s.
The city's position in Sweden also made it a natural archive for medical documentation. The University of Stockholm Archive Catalogue, compiled between 1988 and 1995, draws substantially on Uppsala's holdings of post-war medical research, including institutional records from the Akademiska Sjukhuset and the Institute for Immunological Therapy. These archives preserve the paper record of clinical trials, patient outcome data, and internal correspondence that tracked Sweden's adoption of serum therapy as the primary systemic response to bacterial infection.
References
- 1.The Architecture of Prevention: Hospital Design and Infection Outcomes]], Swedish Medical Journal, vol. 14, no. 2, 1964, pp. 78-94
- 2.Swedish Centre for Infection Surveillance: Annual Reports 1952-1982]], Swedish National Board of Health and Welfare, Stockholm, archival holdings
- 3.Institute for Immunological Therapy Archives]], Uppsala University Library, research records 1963-1995
- 4.Höglund, Sven, Passive Immunization and the Clinical Management of Bacterial Sepsis, Universitetsförlaget, Stockholm, 1966
- 5.University of Stockholm Archive Catalogue]], Swedish National Library, Stockholm, 1994, vol. 3, pp. 156-203